Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis

Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center

(2022) Hyunsue Do et al.   Journal of Rheumatic Diseases

Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea

(2021) Su Jin Choi et al.   Journal of Rheumatic Diseases

An overview of meta-analysis for clinicians

(2018) Young Ho Lee   KOREAN JOURNAL OF INTERNAL MEDICINE

FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis

(2018) Alberto Jiménez Morales et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura

(2017) Hend N. Ellithy et al.   Hematology

The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis

(2016) Duo Liu et al.   ANNALS OF HEMATOLOGY

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2016) Rodrigo Cartin-Ceba et al.   Arthritis & Rheumatology

Fc  receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy

(2014) A. C. J. Stork et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

(2013) Luca Quartuccio et al.   ANNALS OF THE RHEUMATIC DISEASES

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab

(2012) A Ruyssen-Witrand et al.   ANNALS OF THE RHEUMATIC DISEASES

Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis

(2012) Young-Ho Lee et al.   ARCHIVES OF MEDICAL RESEARCH

Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia

(2012) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Association of the FCGR3A-158F/V Gene Polymorphism with the Response to Rituximab Treatment in Spanish Systemic Autoimmune Disease Patients

(2012) Gema Robledo et al.   DNA AND CELL BIOLOGY

Influence ofFCGR3Agenotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study

(2012) Alf Kastbom et al.   BMJ Open

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

(2010) Young Ho Lee et al.   RHEUMATOLOGY INTERNATIONAL

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk

(2009) Soumya Raychaudhuri et al.   NATURE GENETICS

Associations Between FCGR3A Polymorphisms and Susceptibility to Rheumatoid Arthritis: A Metaanalysis

(2008) Young Ho Lee et al.   JOURNAL OF RHEUMATOLOGY